AzTrials
AzTrials

PregnancyNCT02689739

Validation of Ultrasound in Predicting a Low Lying Placenta Throughout Pregnancy

An observational study of Pregnancy and Obese, run by The University of Texas Medical Branch, Galveston at 1 site in United States.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

This is a prospective observational study comparing venous Doppler flow in the lower extremities of pregnant women. Pregnant women with a BMI >/= 30 will be compared to those with a BMI < 30. Read more about this study

Who is it for?
Ages 18 to 50 years, women onlyHealthy volunteers can take part
Conditions the study is for
Pregnancy, Obese
What is being tested?
venous duplex ultrasound
Type of treatment
Surgery or procedure
How many people
0 participants
Where
1 siteUnited States
Study dates
1 Jul 2015to 30 Jun 2016
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Study population: This is a prospective study comparing venous Doppler flow in the lower extremities of pregnant women. Pregnant women with a BMI >/= 30 will be compared to those with a BMI < 30 who deliver at UTMB.

Who may be able to join

  • Age >/= 18 years of age, planned delivery at John Sealy Hospital (JSH)

Who cannot join

  • <18 years of age
  • Personal history of VTE, regardless of etiology
  • Development of VTE during this pregnancy -History of thrombophilia, bleeding disorder marked varicosities, history of recurrent stillbirth, intrauterine growth restriction
  • Any indication for emergency delivery
  • Known major fetal abnormality or genetic syndrome

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Texas Medical Branch

    Galveston, Texas, 77555

Other trials in United States

About this study

Official title: Lower-extremity Blood fl ow and Velocity in Obese vs Nonobese Pregnant Women

This is a prospective observational study comparing venous Doppler flow in the lower extremities of pregnant women. Pregnant women with a BMI >/= 30 will be compared to those with a BMI < 30.

Read the detailed description

Study Outcome Measurement and Ascertainment:

Data will be collected from data in EPIC and UTMB electronic medical records. This information will include:

  1. Maternal demographic data, medical, family, personal, social and surgical history
  2. Maternal pre-pregnancy weight and height
  3. Maternal weight at time of delivery
  4. Maternal weight on post-operative day 1
  5. Gestational age at delivery, infant gender, birth weight, placental weight, delivery method, and complications through 6 weeks postpartum.

Venous hemodynamics will be obtained using venous duplex ultrasound. 1. Peak, mean, and minimum flow velocities and diameter will be obtained. Calculations of venous velocity amplitude, cross-sectional area, and shear stress will be made from the data collected.

Study Procedures:

This is a prospective study using duplex ultrasound techniques to characterize venous flow in obese and non-obese pregnant patients. Women will be consented to participate and then separated into a study group of obese women (BMI >/= 30) and a control group of non-obese women (BMI <30). These women will be admitted to Labor and Delivery for management of pregnancy. The Doppler US will then be performed by trained staff on the lower extremity. The flow data described above will be measured and compared between the two groups. Additional measurements will be collected during hospitalization.

Criteria for Inclusion of Subjects:

-Age >/= 18 years of age, planned delivery at John Sealy Hospital (JSH)

Criteria for Exclusion of Subjects:

  • <18 years of age
  • Personal history of VTE, regardless of etiology
  • Development of VTE during this pregnancy -History of thrombophilia, bleeding disorder marked varicosities, history of recurrent stillbirth, intrauterine growth restriction
  • Any indication for emergency delivery
  • Known major fetal abnormality or genetic syndrome

Sources of Research Material:

The sources of data to be used include maternal medical records from EPIC as well as the data obtained from the venous ultrasound.

Recruitment Methods and Consenting Process:

The subjects will be pregnant women who plan a delivery at JSH. Subjects will be consented by study personnel. Patients will not receive any monetary gain. They will understand that this is voluntary and will not affect their care.

Potential Risks:

The Doppler velocimetry is the modality that has been used in pregnancy to assess for the presence of DVT, thus, the safety has been assessed and widely studied. This poses minimum risk to the mother or to the fetus.

Subject Safety and Data Monitoring:

This study does not place subjects at risk of their safety. This modality is well studied to be safe in pregnancy.

Data monitoring will be performed only by study personnel. Data may be assessed prior to the study being completed to assess to see if statistical analysis reveals any difference and if the study can be stopped early.

Procedures to Maintain Confidentiality:

Data will only be viewed by study personnel. The data will then be de-identified and a study number will be assigned to each patient. The patient's identity will then be secured on an UTMB encrypted laptop device and a hard copy stored in the locked file cabinet in the locked office of the investigator.

Potential Benefits:

There are no benefits to subjects participating in the study. By gathering the information of duplex velocimetry in both the obese and non-obese population we can determine if there is a change in the velocimetry in this at risk population.

Conditions
Pregnancy, Obese
Being tested
venous duplex ultrasound
Medical subject headings
Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • venous duplex ultrasoundProcedure or surgery

    Venous duplex ultrasound

Study groups in NCT02689739
Study groupRoleWhat they receive
Obese Pregnant cohortWomen will be consented to participate and then separated into a study group of obese women (BMI >/= 30).
Receives: Procedure: venous duplex ultrasound
Non-obese Pregnant cohortThis will be the control group of non-obese women (BMI <30).
Receives: Procedure: venous duplex ultrasound

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in venous duplex velocity

    To assess if the increased risk of venous thromboembolism is observed in obese versus non-obese pregnant patients is due to compromised flow in the lower extremities.

    Measured: On admission for delivery of the infant and postpartum day 1 and 2

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Feb 2016 (estimated)
  2. Study start1 Jul 2015
  3. Primary completion30 Jun 2016
  4. Study completion30 Jun 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02689739
Sponsor's protocol ID
15-0143
Status last verified
Mar 2019
First submitted
13 Feb 2016
Last updated
26 Oct 2020
Results posted
No
Data monitoring committee
No
Individual data sharing
No: We do not plan to share data.

Questions about this trial

What is this clinical trial studying?

An observational study of Pregnancy and Obese, run by The University of Texas Medical Branch, Galveston at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 26 Oct 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in venous duplex velocity (time frame: On admission for delivery of the infant and postpartum day 1 and 2). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Oct 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in